PATENT CLAIM ANALYSIS

Application Number: 15781839
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "158100"]

Abstract:
The present invention relates to methods and pharmaceutical compositions for the treatment of systemic sclerosis. In particular, the present invention relates to a method of treating systemic sclerosis in a subject in need thereof comprising administering to the subject a therapeutically effective amount of vanin-1 inhibitor.

Claim (Index 5):
A method of treating systemic sclerosis in a subject in need thereof comprising i) determining the level of vanin-1 activity in a blood sample obtained from the subject ii) comparing the level determined at step i) with a predetermined reference value and iii) administering to the subject a therapeutically effective amount of a vanin-1 inhibitor when the level determined at step i) is higher than the predetermined reference value.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.48485
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14390562', '14471968', '13138608', '15627755', '14642546']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.645233363642946
- 35 USC 102 Novelty (BERT): 0.4897038255362937
- Combined Prediction Score: 0.6296804098322808
- Mean Citation Score: 144.52459800000003
- Max Citation Score: 150.77945
- Similarity Product: 99.33195676077008

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test